Sale!

ATXN1 Gene Spinocerebellar Ataxia Type 1 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATXN1 gene is associated with Spinocerebellar Ataxia Type 1 (SCA1), a progressive, neurodegenerative disorder characterized by a loss of coordination and balance. This condition is inherited in an autosomal dominant pattern, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder. The ATXN1 gene test is a genetic test designed to detect mutations in the ATXN1 gene, confirming the diagnosis of SCA1 and facilitating genetic counseling for affected families.

DNA Labs UAE offers the ATXN1 gene test for individuals suspected of having Spinocerebellar Ataxia Type 1 or for those with a family history of the disorder. The test is crucial for early diagnosis, management, and understanding the risk of transmission to future generations. The cost of the ATXN1 gene test at DNA Labs UAE is 4400 AED. Conducted in a state-of-the-art laboratory setting, this genetic test provides a reliable diagnosis, guiding treatment plans and support for affected individuals and their families.

Description

ATXN1 Gene Spinocerebellar Ataxia Type 1 Autosomal Dominant Genetic Test

Genetic testing is an important tool in diagnosing and understanding genetic disorders. At DNA Labs UAE, we offer the ATXN1 Gene Spinocerebellar Ataxia Type 1 Autosomal Dominant Genetic Test to help individuals and families affected by this condition.

Test Components and Price

Test Name: ATXN1 Gene Spinocerebellar Ataxia Type 1 Autosomal Dominant Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition and Report Delivery

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type and Doctor

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department

Test Department: Genetics

Pre Test Information

Clinical History of Patient: A Genetic Counselling session to draw a pedigree chart of family members affected with ATXN1 Gene Spinocerebellar Ataxia Type 1, autosomal dominant

Test Details

The ATXN1 gene is associated with Spinocerebellar Ataxia Type 1 (SCA1), which is an autosomal dominant genetic disorder. SCA1 is characterized by progressive degeneration of the cerebellum, leading to impaired coordination and balance, as well as other neurological symptoms.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, including the ATXN1 gene, to identify any mutations or variations that may be present. This type of testing can help diagnose SCA1 and determine if an individual has inherited the condition.

During the NGS genetic test, a small sample of the individual’s DNA, usually obtained through a blood sample or cheek swab, is analyzed. The DNA is sequenced, and any variations in the ATXN1 gene or other genes associated with ataxias are identified. These variations can then be compared to known disease-causing mutations to determine if the individual has SCA1.

NGS genetic testing for SCA1 can be useful in confirming a diagnosis, as well as in providing information about the inheritance pattern and the likelihood of passing the condition on to future generations. It can also be used for carrier testing in individuals who have a family history of SCA1 but do not show symptoms themselves.

It is important to note that genetic testing for SCA1 should be performed by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support throughout the testing process.

Test Name	ATXN1 Gene Spinocerebellar ataxia type 1 autosomal dominant Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ATXN1 Gene Spinocerebellar ataxia type 1, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATXN1 Gene Spinocerebellar ataxia type 1, autosomal dominant
Test Details	The ATXN1 gene is associated with Spinocerebellar Ataxia Type 1 (SCA1), which is an autosomal dominant genetic disorder. SCA1 is characterized by progressive degeneration of the cerebellum, leading to impaired coordination and balance, as well as other neurological symptoms. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, including the ATXN1 gene, to identify any mutations or variations that may be present. This type of testing can help diagnose SCA1 and determine if an individual has inherited the condition. During the NGS genetic test, a small sample of the individual’s DNA, usually obtained through a blood sample or cheek swab, is analyzed. The DNA is sequenced, and any variations in the ATXN1 gene or other genes associated with ataxias are identified. These variations can then be compared to known disease-causing mutations to determine if the individual has SCA1. NGS genetic testing for SCA1 can be useful in confirming a diagnosis, as well as in providing information about the inheritance pattern and the likelihood of passing the condition on to future generations. It can also be used for carrier testing in individuals who have a family history of SCA1 but do not show symptoms themselves. It is important to note that genetic testing for SCA1 should be performed by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support throughout the testing process.

Browse

Want to chat?

Social